Brief: Axcella Reports Fourth Quarter And Full Year 2022 Financial Results
March 30 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* LONG COVID PHASE 2B/3 STUDY MAY PROCEED UNDER U.S.
INVESTIGATIONAL NEW DRUG APPLICATION
* AS OF DECEMBER 31, 2022, CASH AND CASH EQUIVALENTS TOTALED
$17.1
MILLION
* QTRLY LOSS PER SHARE $0.33
* Q4 EARNINGS PER SHARE VIEW $-0.30 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw4vgjfTa
Further company coverage: AXLA.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment